Therapy combining three antiviral drugs is safer and more effective than single-drug treatments in reducing the viral load in less severe Covid-19 patients, a small trial undertaken by the University of Hong Kong has discovered.
The study, published in The Lancet on Saturday, comprised 127 adults with mild-to-moderate symptoms of Covid-19.
The team found that using the three drugs -- lopinavir-ritonavir, an anti-HIV therapy; ribavirin, a hepatitis C treatment; and interferon beta-1b, developed to combat multiple sclerosis -- halved the time needed to completely alleviate symptoms and meant a shorter stay in hospital.
您已阅读37%（622字），剩余63%（1081字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。